Neuropsychological testing and assessment for dementia
Claudia Jacova
Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
Search for more papers by this authorAndrew Kertesz
Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada
Search for more papers by this authorMervin Blair
Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada
Search for more papers by this authorJohn D. Fisk
QE II Health Sciences Centre, Departments of Psychiatry, Medicine and Psychology, Dalhousie University, Halifax, Nova Scotia, Canada
Search for more papers by this authorCorresponding Author
Howard H. Feldman
- [email protected]
- (604) 822-7979 | Fax: (604) 822-7703
Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
Corresponding author. Tel.: (604) 822-7979; Fax: (604) 822-7703. E-mail address: [email protected]
Search for more papers by this authorClaudia Jacova
Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
Search for more papers by this authorAndrew Kertesz
Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada
Search for more papers by this authorMervin Blair
Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada
Search for more papers by this authorJohn D. Fisk
QE II Health Sciences Centre, Departments of Psychiatry, Medicine and Psychology, Dalhousie University, Halifax, Nova Scotia, Canada
Search for more papers by this authorCorresponding Author
Howard H. Feldman
- [email protected]
- (604) 822-7979 | Fax: (604) 822-7703
Division of Neurology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
Corresponding author. Tel.: (604) 822-7979; Fax: (604) 822-7703. E-mail address: [email protected]
Search for more papers by this authorAbstract
This evidence-based review examines the utility of brief cognitive tests and neuropsychological testing (NPT) in the detection and diagnosis of mild cognitive impairment (MCI) and dementia. All patients presenting with cognitive complaints are recommended to have a brief screening test administered to document the presence and severity of memory/cognitive deficits. There is fair evidence to support the use of a range of new screening tests that can detect MCI and mild dementia with higher sensitivity (≥80%) than the Mini-Mental State Exam (MMSE). NPT should be part of a clinically integrative approach to the diagnosis and differential diagnosis of dementia. It should be applied selectively to address specific clinical and diagnostic issues including: 1) The distinction between normal cognitive functioning in the aged, MCI and early dementia: there is fair evidence that NPT can document the presence of specific diagnostic criteria and provide additional useful information on the pattern of memory/cognitive impairment. 2) The evaluation of risk for Alzheimer disease (AD) or other types of dementia in persons with MCI: there is fair evidence that NPT measures or profiles can predict progression to dementia (predictive accuracy ranges from ∼80 to 100%, sensitivities from 53 to 80%, and specificities from 67 to 99%). 3) Differential diagnosis: There is fair evidence that NPT can complement clinical history and neuroimaging in determining the dementia etiology. Different dementia types have distinguishable NPT profiles though these may be stage-dependent, and increased sensitivity may be at the expense of specificity. 4) When NPT is part of a comprehensive assessment, which also entails clinical interviews and consideration of other clinical data, there is good evidence that it can contribute to management decisions in MCI and dementia, including the determination of retained and impaired cognitive abilities, their functional and vocational impact, and opportunities for cognitive rehabilitation.
References
- [1] The Houston conference on specialty education and training in clinical neuropsychology. Policy statement. Archives of Clinical Neuropsychology 1998; 157–250.
- [2]S.A. Mulherin, W.C. Miller. Spectrum bias or spectrum effect? subgroup variation in diagnostic test evaluation. Ann Intern Med. 137: 2002; 598–602
- [3]W.J. Lorentz, J.M. Scanlan, S. Borson. Brief screening tests for dementia. Can J Psychiatry. 47: 2002; 723–733
- [4]M.F. Folstein, L.N. Robins, J.E. Helzer. The Mini-Mental State Examination. Arch Gen Psychiatry. 40: 1983; 812
- [5]T.N. Tombaugh, N.J. McIntyre. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc. 40: 1992; 922–935
- [6]T.N. Tombaugh, I. McDowell, B. Kristjansson, A.M. Hubley. Mini-Mental State Examination (MMSE) and the modified MMSE (3MS): a psychometric comparison and normative data. Psychol Assess. 8: 1996; 48–59
- [7]J. Lindsay, D. Laurin, R. Verreault, R. Hebert, B. Helliwell, G.B. Hill, et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol. 156: 2002; 445–453
- [8]H.C. Kraemer, D.J. Moritz, J. Yesavage. Adjusting Mini-Mental State Examination scores for age and educational level to screen for dementia: correcting bias or reducing validity? Int Psychogeriatr. 10: 1998; 43–51
- [9]H.H. Feldman, C. Jacova. Mild cognitive impairment. Am J Geriatr Psychiatry. 13: 2005; 645–655
- [10]R.C. Petersen, G.E. Smith, S.C. Waring, R.J. Ivnik, E.G. Tangalos, E. Kokmen. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 56: 1999; 303–308
- [11]J.E. Graham, K. Rockwood, B.L. Beattie, R. Eastwood, S. Gauthier, H. Tuokko, et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet. 349: 1997; 1793–1796
- [12]J.D. Fisk, H.R. Merry, K. Rockwood. Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology. 61: 2003; 1179–1184
- [13]H. Feldman, A.R. Levy, G.Y. Hsiung, K.R. Peters, A. Donald, S.E. Black, et al. A Canadian cohort study of cognitive impairment and related dementias (ACCORD): study methods and baseline results. Neuroepidemiology. 22: 2003; 265–274
- [14]R.C. Petersen, J.C. Stevens, M. Ganguli, E.G. Tangalos, J.L. Cummings, S.T. DeKosky. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review)—report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 56: 2001; 1133–1142
- [15]Z.S. Nasreddine, N.A. Phillips, V. Bedirian, S. Charbonneau, V. Whitehead, I. Collin, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 53: 2005; 695–699
- [16]E. Kalbe, J. Kessler, P. Calabrese, R. Smith, A.P. Passmore, M. Brand, et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry. 19: 2004; 136–143
- [17]D.A. Loewenstein, W.W. Barker, D.G. Harwood, C. Luis, A. Acevedo, I. Rodriguez, et al. Utility of a modified Mini-Mental State Examination with extended delayed recall in screening for mild cognitive impairment and dementia among community dwelling elders. Int J Geriatr Psychiatry. 15: 2000; 434–440
- [18]D.F. Tang-Wai, D.S. Knopman, Y.E. Geda, S.D. Edland, G.E. Smith, R.J. Ivnik, et al. Comparison of the short test of mental status and the mini-mental state examination in mild cognitive impairment. Arch Neurol. 60: 2003; 1777–1781
- [19]A. Eibenstein, A.B. Fioretti, M.N. Simaskou, P. Sucapane, S. Mearelli, C. Mina, et al. Olfactory screening test in mild cognitive impairment. Neurol Sci. 26: 2005; 156–160
- [20]R.L. Doty, P.F. Reyes, T. Gregor. Presence of both odor identification and detection deficits in Alzheimer's disease. Brain Res Bull. 18: 1987; 597–600
- [21]C.D. Morgan, C. Murphy. Olfactory event-related potentials in Alzheimer's disease. J Int Neuropsychol Soc. 8: 2002; 753–763
- [22]E.L. Teng, H.C. Chui. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 48: 1987; 314–318
- [23]I. McDowell, G. Hill, J. Lindsay, B. Helliwell, L. Costa, B.L. Beattie, et al. Canadian Study of Health and Aging: study methods and prevalence of dementia. CMAJ. 150: 1994; 899–913
- [24]H. Tuokko, T. Hadjistavropoulos, J.A. Miller, B.L. Beattie. The Clock Test: a sensitive measure to differentiate normal elderly from those with Alzheimer disease. J Am Geriatr Soc. 40: 1992; 579–584
- [25]C. Bush, J. Kozak, T. Elmslie. Screening for cognitive impairment in the elderly. Can Fam Physician. 43: 1997; 1763–1768
- [26]K.I. Shulman. Clock-drawing: is it the ideal cognitive screening test? Int J Geriatr Psychiatry. 15: 2000; 548–561
- [27]J.C. Morris. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 9 (Suppl 1): 1997; 173–176
- [28]K.K. Powlishta, D.D. Von Dras, A. Stanford, D.B. Carr, C. Tsering, J.P. Miller, et al. The clock drawing test is a poor screen for very mild dementia. Neurology. 59: 2002; 898–903
- [29]J. De Lepeleire, J. Heyman, F. Baro, F. Buntinx. A combination of tests for the diagnosis of dementia had a significant diagnostic value. J Clin Epidemiol. 58: 2005; 217–225
- [30]H.B. Stahelin, A.U. Monsch, R. Spiegel. Early diagnosis of dementia via a two-step screening and diagnostic procedure. Int Psychogeriatr. 9 (Suppl 1): 1997; 123–130
- [31]P.R. Solomon, A. Hirschoff, B. Kelly, M. Relin, M. Brush, R.D. DeVeaux, et al. A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease. Arch Neurol. 55: 1998; 349–355
- [32]P.R. Solomon, M. Brush, V. Calvo, F. Adams, R.D. DeVeaux, W.W. Pendlebury, et al. Identifying dementia in the primary care practice. Int Psychogeriatr. 12: 2000; 483–493
- [33]G. Kuslansky, H. Buschke, M. Katz, M. Sliwinski, R.B. Lipton. Screening for Alzheimer's disease: the memory impairment screen versus the conventional three-word memory test. J Am Geriatr Soc. 50: 2002; 1086–1091
- [34]H. Brodaty, D. Pond, N.M. Kemp, G. Luscombe, L. Harding, K. Berman, et al. The GPCOG: A new screening test for dementia designed for general practice. J Am Geriatr Soc. 50: 2002; 530–534
- [35]S. Kilada, A. Gamaldo, E.A. Grant, A. Moghekar, J.C. Morris, R.J. O'Brien. Brief screening tests for the diagnosis of dementia: comparison with the mini-mental state exam. Alzheimer Dis Assoc Disord. 19: 2005; 8–16
- [36]J.E. Storey, J.T. Rowland, D. Basic, D.A. Conforti, H.G. Dickson. The Rowland Universal Dementia Assessment Scale (RUDAS): a multicultural cognitive assessment scale. Int Psychogeriatr. 16: 2004; 13–31
- [37]S. Darvesh, L. Leach, S.E. Black, E. Kaplan, M. Freedman. The behavioural neurology assessment. Can J Neurol Sci. 32: 2005; 167–177
- [38]D.T. Stuss, N. Meiran, D.A. Guzman, G. Lafleche, J. Willmer. Do long tests yield a more accurate diagnosis of dementia than short tests? a comparison of 5 neuropsychological tests. Arch Neurol. 53: 1996; 1033–1039
- [39]H. Chui, Q. Zhang. Evaluation of dementia: a systematic study of the usefulness of the American Academy of Neurology's practice parameters. Neurology. 49: 1997; 925–935
- [40]H. Chertkow, H. Bergman, H.M. Schipper, S. Gauthier, R. Bouchard, S. Fontaine, et al. Assessment of suspected dementia. Can J Neurol Sci. 28 (Suppl 1): 2001; 28–41
- [41]G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, E.M. Stadlan. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34: 1984; 939–944
- [42]R. Levy. Aging-associated cognitive decline: Working Party of the International Psychogeriatric Association in collaboration with the World Health Organization. Int Psychogeriatr. 6: 1994; 63–68
- [43]K.R. Peters, P. Graf, S. Hayden, H. Feldman. Neuropsychological characterization of cognitively-impaired-not-demented (CIND) individuals: clinical comparison data. Clin Neuropsychol. 18: 2004; 208–228
- [44]K.R. Peters, P. Graf, S. Hayden, H. Feldman. Neuropsychological subgroups of cognitively-impaired-not-demented (CIND) individuals: delineation, reliability, and predictive validity. J Clin Exp Neuropsychol. 27: 2005; 164–188
- [45]O.L. Lopez, J.T. Becker, W.J. Jagust, A. Fitzpatrick, M.C. Carlson, S.T. DeKosky, et al. Neuropsychological characteristics of mild cognitive impairment subgroups. J Neurol Neurosurg Psychiatry. 77: 2006; 159–165
- [46]M. Grundman, R.C. Petersen, S.H. Ferris, R.G. Thomas, P.S. Aisen, D.A. Bennett, et al. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 61: 2004; 59–66
- [47]J.H. Kramer, A. Nelson, J.K. Johnson, K. Yaffe, S. Glenn, H.J. Rosen, et al. Multiple cognitive deficits in amnestic mild cognitive impairment. Dement Geriatr Cogn Disord. 22: 2006; 306–311
- [48]A. Collie, P. Maruff, J. Currie. Behavioral characterization of mild cognitive impairment. J Clin Exp Neuropsychol. 24: 2002; 720–733
- [49]K. Welsh, N. Butters, J. Hughes, R. Mohs, A. Heyman. Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol. 48: 1991; 278–281
- [50]D.A. Cahn, D.P. Salmon, N. Butters, W.C. Wiederholt, J. Corey-Bloom, S.L. Edelstein, et al. Detection of dementia of the Alzheimer type in a population-based sample: neuropsychological test performance. J Int Neuropsychol Soc. 1: 1995; 252–260
- [51]J.M. Swearer, B.F. O'Donnell, K.J. Kane, N.E. Hoople, M. Lavoie. Delayed recall in dementia: sensitivity and specificity in patients with higher than average general intellectual abilities. Neuropsychiatry Neuropsychol Behav Neurol. 11: 1998; 200–206
- [52] American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text revision (DSM-IV-TR). 2000; American Psychiatric Association: Arlington, VA
- [53]R.E. Steenhuis, T. Ostbye. Neuropsychological test performance of specific diagnostic groups in the Canadian Study of Health and Aging (CSHA). J Clin Exp Neuropsychol. 17: 1995; 773–785
- [54]M.A. Lambon Ralph, K. Patterson, N. Graham, K. Dawson, J.R. Hodges. Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases. Brain. 126 (Pt 11): 2003; 2350–2362
- [55]B.J. Small, L. Fratiglioni, M. Viitanen, B. Winblad, L. Backman. The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol. 57: 2000; 839–844
- [56]C.B. Hall, R.B. Lipton, M. Sliwinski, W.F. Stewart. A change point model for estimating the onset of cognitive decline in preclinical Alzheimer's disease. Stat Med. 19: 2000; 1555–1566
- [57]E.H. Rubin, M. Storandt, J.P. Miller, D.A. Kinscherf, E.A. Grant, J.C. Morris, et al. A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol. 55: 1998; 395–401
- [58]H. Amieva, H. Jacqmin-Gadda, J.M. Orgogozo, N. Carret, C. Helmer, L. Letenneur, et al. The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study. Brain. 128 (Pt 5): 2005; 1093–1101
- [59]P. Chen, G. Ratcliff, S.H. Belle, J.A. Cauley, S.T. DeKosky, M. Ganguli. Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry. 58: 2001; 853–858
- [60]P. Maruff, A. Collie, D. Darby, J. Weaver-Cargin, C. Masters, J. Currie. Subtle memory decline over 12 months in mild cognitive impairment. Dement Geriatr Cogn Disord. 18: 2004; 342–348
- [61]K.S. Fowler, M.M. Saling, E.L. Conway, J.M. Semple, W.J. Louis. Paired associate performance in the early detection of DAT. J Int Neuropsychol Soc. 8: 2002; 58–71
- [62]J. Bowen, L. Teri, W. Kukull, W. McCormick, S.M. McCurry, E.B. Larson. Progression to dementia in patients with isolated memory loss. Lancet. 349: 1997; 763–765
- [63]M.C. Tierney, C. Yao, A. Kiss, I. McDowell. Neuropsychological tests accurately predict incident Alzheimer disease after 5 and 10 years. Neurology. 64: 2005; 1853–1859
- [64]M.C. Tierney, J.P. Szalai, W.G. Snow, R.H. Fisher, A. Nores, G. Nadon, et al. Prediction of probable Alzheimer's disease in memory-impaired patients: a prospective longitudinal study. Neurology. 46: 1996; 661–665
- [65]E. Arnaiz, O. Almkvist, R.J. Ivnik, E.G. Tangalos, L.O. Wahlund, B. Winblad, et al. Mild cognitive impairment: a cross-national comparison. J Neurol Neurosurg Psychiatry. 75: 2004; 1275–1280
- [66]S. Artero, K. Ritchie. The detection of mild cognitive impairment in the general practice setting. Aging Ment Health. 7: 2003; 251–258
- [67]M.F. Elias, A. Beiser, P.A. Wolf, R. Au, R.F. White, R.B. D'Agostino. The preclinical phase of Alzheimer disease: a 22-year prospective study of the Framingham Cohort. Arch Neurol. 57: 2000; 808–813
- [68]D.B. Howieson, A. Dame, R. Camicioli, G. Sexton, H. Payami, J.A. Kaye. Cognitive markers preceding Alzheimer's dementia in the healthy oldest old. J Am Geriatr Soc. 45: 1997; 584–589
- [69]A.D. Blackwell, B.J. Sahakian, R. Vesey, J.M. Semple, T.W. Robbins, J.R. Hodges. Detecting dementia: novel neuropsychological markers of preclinical Alzheimer's disease. Dement Geriatr Cogn Disord. 17: 2004; 42–48
- [70]K. Palmer, L. Backman, B. Winblad, L. Fratiglioni. Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. BMJ. 326: 2003; 245
- [71]D.P. Devanand, M. Folz, M. Gorlyn, J.R. Moeller, Y. Stern. Questionable dementia: clinical course and predictors of outcome. J Am Geriatr Soc. 45: 1997; 321–328
- [72]A. Bozoki, B. Giordani, J.L. Heidebrink, S. Berent, N.L. Foster. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss. Arch Neurol. 58: 2001; 411–416
- [73]L. Backman, S. Jones, A.K. Berger, E.J. Laukka, B.J. Small. Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis. Neuropsychology. 19: 2005; 520–531
- [74]A. Herlitz, B.J. Small, L. Fratiglioni, O. Almkvist, M. Viitanen, L. Backman. Detection of mild dementia in community surveys: is it possible to increase the accuracy of our diagnostic instruments? Arch Neurol. 54: 1997; 319–324
- [75]J. Tian, R.S. Bucks, J. Haworth, G. Wilcock. Neuropsychological prediction of conversion to dementia from questionable dementia: statistically significant but not yet clinically useful. J Neurol Neurosurg Psychiatry. 74: 2003; 433–438
- [76]C. Fabrigoule, I. Rouch, A. Taberly, L. Letenneur, D. Commenges, J.M. Mazaux, et al. Cognitive process in preclinical phase of dementia. Brain. 121 (Pt 1): 1998; 135–141
- [77]K. Ritchie, D. Leibovici, B. Ledesert, J. Touchon. A typology of sub-clinical senescent cognitive disorder. Br J Psychiatry. 168: 1996; 470–476
- [78]R.J. Ivnik, G.E. Smith, J.H. Cerhan, B.F. Boeve, E.G. Tangalos, R.C. Petersen. Understanding the diagnostic capabilities of cognitive tests. Clin Neuropsychol. 15: 2001; 114–124
- [79]D. Neary, J. Snowden, D. Mann. Frontotemporal dementia. Lancet Neurol. 4: 2005; 771–780
- [80]H. Feldman, A. Kertesz. Diagnosis, classification and natural history of degenerative dementias. Can J Neurol Sci. 28 (Suppl 1): 2001; S17–S27
- [81]L. Gustafson. Frontal lobe degeneration of non-Alzheimer type: II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 6: 1987; 209–223
- [82]D. Neary, J.S. Snowden, B. Northen, P. Goulding. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry. 51: 1988; 353–361
- [83]D. Aarsland, I. Litvan, D. Salmon, D. Galasko, T. Wentzel-Larsen, J.P. Larsen. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 74: 2003; 1215–1220
- [84]C.G. Ballard, G. Ayre, J. O'Brien, A. Sahgal, I.G. McKeith, P.G. Ince, et al. Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord. 10: 1999; 104–108
- [85]J. Calderon, R.J. Perry, S.W. Erzinclioglu, G.E. Berrios, T.R. Dening, J.R. Hodges. Perception, attention, and working memory are disproportionately impaired in dementia with Lewy bodies compared with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 70: 2001; 157–164
- [86]I. Litvan, E. Mohr, J. Williams, C. Gomez, T.N. Chase. Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 54: 1991; 25–29
- [87]J.C. Looi, P.S. Sachdev. Differentiation of vascular dementia from AD on neuropsychological tests. Neurology. 53: 1999; 670–678
- [88]S. Corkin. Some relationships between global amnesia and the memory impairment in Alzheimer's disease S. Corkin, K. Davis, J.H. Growdon. Alzheimer's disease: a report of progress on research. 1982; Raven Press: New York; 149–164
- [89]T. Karlsson, L. Backman, A. Herlitz, L.G. Nilsson, B. Winblad, P.O. Osterlind. Memory improvement at different stages of Alzheimer's disease. Neuropsychologia. 27: 1989; 737–742
- [90]A. Martin, P. Brouwers, C. Cox, P. Fedio. On the nature of the verbal memory deficit in Alzheimer's disease. Brain Lang. 25: 1985; 323–341
- [91]J.R. Hodges. Frontotemporal dementia (Pick's disease): clinical features and assessment. Neurology. 56 (Suppl 4): 2001; 6–10
- [92]F. Pasquier, L. Grymonprez, F. Lebert, M. Van der Linden. Memory impairment differs in frontotemporal dementia and Alzheimer's disease. Neurocase. 7: 2001; 161–171
- [93]D. Collerton, D. Burn, I. McKeith, J. O'Brien. Systematic review and meta-analysis show that dementia with Lewy bodies is a visual-perceptual and attentional-executive dementia. Dement Geriatr Cogn Disord. 16: 2003; 229–237
- [94]E.K. Doubleday, J.S. Snowden, A.R. Varma, D. Neary. Qualitative performance characteristics differentiate dementia with Lewy bodies and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 72: 2002; 602–607
- [95]M. Emre. Dementia associated with Parkinson's disease. Lancet Neurol. 2: 2003; 229–237
- [96]C.G. Ballard, D. Aarsland, I. McKeith, J. O'Brien, A. Gray, F. Cormack, et al. Fluctuations in attention: PD dementia vs DLB with parkinsonism. Neurology. 59: 2002; 1714–1720
- [97]M.F. Mendez, J.L. Cummings. Dementia: a clinical approach, 3 ed. 2003; Butterworth-Heinemann (Elsevier): Philadelphia
- [98]J.M. Hamilton, D.P. Salmon, D. Galasko, D.C. Delis, L.A. Hansen, E. Masliah, et al. A comparison of episodic memory deficits in neuropathologically-confirmed dementia with Lewy bodies and Alzheimer's disease. J Int Neuropsychol Soc. 10: 2004; 689–697
- [99]E.L. Helkala, V. Laulumaa, H. Soininen, P.J. Riekkinen Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases. Ann Neurol; 24: 214–7.
- [100]B. Pillon, B. Deweer, Y. Agid, B. Dubois. Explicit memory in Alzheimer's, Huntington's, and Parkinson's diseases. Arch Neurol. 50: 1993; 374–379
- [101]M.C. Tierney, S.E. Black, J.P. Szalai, W.G. Snow, R.H. Fisher, G. Nadon, et al. Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch Neurol. 58: 2001; 1654–1659
- [102]R.J. Branconnier, J.O. Cole, K.F. Spera, D.R. DeVitt. Recall and recognition as diagnostic indices of malignant memory loss in senile dementia: a Bayesian analysis. Exp Aging Res. 8: 1982; 189–193
- [103]P.E. Davis, S.J. Mumford. Cued recall and the nature of the memory disorder in dementia. Br J Psychiatry. 144: 1984; 383–386
- [104]P. Chen, G. Ratcliff, S.H. Belle, J.A. Cauley, S.T. DeKosky, M. Ganguli. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology. 55: 2000; 1847–1853
- [105]M. Grossman. Frontotemporal dementia: a review. J Int Neuropsychol Soc. 8: 2002; 566–583
- [106]A. Kertesz, W. Davidson, P. McCabe, D. Munoz. Behavioral quantitation is more sensitive than cognitive testing in frontotemporal dementia. Alzheimer Dis Assoc Disord. 17: 2003; 223–229
- [107]K. Faber-Langendoen, J.C. Morris, J.W. Knesevich, E. LaBarge, J.P. Miller, L. Berg. Aphasia in senile dementia of the Alzheimer type. Ann Neurol. 23: 1988; 365–370
- [108]A. Kertesz, J. Appell, M. Fisman. The dissolution of language in Alzheimer's disease. Can J Neurol Sci. 13 (Suppl): 1986; 415–418
- [109]J. Appell, A. Kertesz, M. Fisman. A study of language functioning in Alzheimer patients. Brain Lang. 17: 1982; 73–91
- [110]J.L. Cummings, A. Darkins, M. Mendez, M.A. Hill, D.F. Benson. Alzheimer's disease and Parkinson's disease: comparison of speech and language alterations. Neurology. 38: 1988; 680–684
- [111]S.J. Huber, E.C. Shuttleworth, D.L. Freidenberg. Neuropsychological differences between the dementias of Alzheimer's and Parkinson's diseases. Arch Neurol. 46: 1989; 1287–1291
- [112]M. Grossman, S. Carvell, S. Gollomp, M.B. Stern, G. Vernon, H.I. Hurtig. Sentence comprehension and praxis deficits in Parkinson's disease. Neurology. 41: 1991; 1620–1626
- [113]M. Grossman, S. Carvell, M.B. Stern, S. Gollomp, H.I. Hurtig. Sentence comprehension in Parkinson's disease: the role of attention and memory. Brain Lang. 42: 1992; 347–384
- [114]D. Howard, K. Patterson. Pyramids and palm trees: a test of semantic access from pictures and words. 1992; Thames Valley Test Company: St Edmunds, Suffolk, UK
- [115]T. Shimomura, E. Mori, H. Yamashita, T. Imamura, N. Hirono, M. Hashimoto, et al. Cognitive loss in dementia with Lewy bodies and Alzheimer disease. Arch Neurol. 55: 1998; 1547–1552
- [116]F. Cormack, D. Aarsland, C. Ballard, M.J. Tovee. Pentagon drawing and neuropsychological performance in dementia with Lewy bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. Int J Geriatr Psychiatry. 19: 2004; 371–377
- [117]Y. Stern, M. Richards, M. Sano, R. Mayeux. Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease. Arch Neurol. 50: 1993; 1040–1045
- [118]Y. Stern, R. Mayeux, J. Rosen, J. Ilson. Perceptual motor dysfunction in Parkinson's disease: a deficit in sequential and predictive voluntary movement. J Neurol Neurosurg Psychiatry. 46: 1983; 145–151
- [119]K. Rascovsky, D.P. Salmon, G.J. Ho, D. Galasko, G.M. Peavy, L.A. Hansen, et al. Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology. 58: 2002; 1801–1808
- [120]D. Bathgate, J.S. Snowden, A. Varma, A. Blackshaw, D. Neary. Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia. Acta Neurol Scand. 103: 2001; 367–378
- [121]S. Bozeat, C.A. Gregory, M.A. Ralph, J.R. Hodges. Which neuropsychiatric and behavioural features distinguish frontal and temporal variants of frontotemporal dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry. 69: 2000; 178–186
- [122]A. Kertesz, W. Davidson, H. Fox. Frontal behavioral inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci. 24: 1997; 29–36
- [123]A. Kertesz, N. Nadkarni, W. Davidson, A.W. Thomas. The Frontal Behavioral Inventory in the differential diagnosis of frontotemporal dementia. J Int Neuropsychol Soc. 6: 2000; 460–468
- [124]M.L. Levy, B.L. Miller, J.L. Cummings, L.A. Fairbanks, A. Craig. Alzheimer disease and frontotemporal dementias: behavioral distinctions. Arch Neurol. 53: 1996; 687–690
- [125]B.L. Miller, C. Ikonte, M. Ponton, M. Levy, K. Boone, A. Darby, et al. A study of the Lund-Manchester research criteria for frontotemporal dementia: clinical and single-photon emission CT correlations. Neurology. 48: 1997; 937–942
- [126]R.R. Davies, J.R. Hodges, J.J. Kril, K. Patterson, G.M. Halliday, J.H. Xuereb. The pathological basis of semantic dementia. Brain. 128 (Pt 9): 2005; 1984–1995
- [127]C.A. Marczinski, W. Davidson, A. Kertesz. A longitudinal study of behavior in frontotemporal dementia and primary progressive aphasia. Cogn Behav Neurol. 17: 2004; 185–190
- [128]D.P. Devanand. The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease. Alzheimer Dis Assoc Disord. 13 (Suppl 2): 1999; S3–S8
- [129]M.F. Mendez, R.J. Martin, K.A. Smyth, P.J. Whitehouse. Psychiatric symptoms associated with Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 2: 1990; 28–33
- [130]J.S. Paulsen, D.P. Salmon, L.J. Thal, R. Romero, C. Weisstein-Jenkins, D. Galasko, et al. Incidence of and risk factors for hallucinations and delusions in patients with probable AD. Neurology. 54: 2000; 1965–1971
- [131]C. Ballard, C. Holmes, I. McKeith, D. Neill, J. O'Brien, N. Cairns, et al. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. Am J Psychiatry. 156: 1999; 1039–1045
- [132]D. Aarsland, C. Ballard, J.P. Larsen, I. McKeith. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int J Geriatr Psychiatry. 16: 2001; 528–536
- [133]D. Aarsland, J.L. Cummings, J.P. Larsen. Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease. Int J Geriatr Psychiatry. 16: 2001; 184–191
- [134]G. Fenelon, F. Mahieux, R. Huon, M. Ziegler. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain. 123 (Pt 4): 2000; 733–745
- [135]C. Ballard, D. Neill, J. O'Brien, I.G. McKeith, P. Ince, R. Perry. Anxiety, depression and psychosis in vascular dementia: prevalence and associations. J Affect Disord. 59: 2000; 97–106
- [136]J.L. Cummings, B. Miller, M.A. Hill, R. Neshkes. Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch Neurol. 44: 1987; 389–393
- [137]S.E. Starkstein, L. Sabe, S. Vazquez, A. Teson, G. Petracca, E. Chemerinski, et al. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke. 27: 1996; 408–414
- [138]D.L. Sultzer, H.S. Levin, M.E. Mahler, W.M. High, J.L. Cummings. A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease. Am J Psychiatry. 150: 1993; 1806–1812
- [139]S. Srikanth, A.V. Nagaraja, E. Ratnavalli. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia. J Neurol Sci. 236: 2005; 43–48
- [140]R. Rao, R. Howard. Vascular dementia: dead or alive? Int J Geriatr Psychiatry. 13: 1998; 277–284
- [141]M. Freedman, L. Leach, E. Kaplan, K.I. Shulman Clock drawing: a neuropsychological analysis 1994; Oxford University Press: New York
- [142]D.A. Cahn-Weiner, K. Williams, J. Grace, G. Tremont, H. Westervelt, R.A. Stern. Discrimination of dementia with Lewy bodies from Alzheimer disease and Parkinson disease using the clock drawing test. Cogn Behav Neurol. 16: 2003; 85–92
- [143]I. Rouleau, D.P. Salmon, N. Butters, C. Kennedy, K. McGuire. Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn. 18: 1992; 70–87
- [144]I. Rouleau, D.P. Salmon, N. Butters. Longitudinal analysis of clock drawing in Alzheimer's disease patients. Brain Cogn. 31: 1996; 17–34
- [145]C.A. Gregory, J.R. Hodges. Clinical features of frontal lobe dementia in comparison to Alzheimer's disease. J Neural Transm Suppl. 47: 1996; 103–123
- [146]B.L. Miller, J.L. Cummings, J. Villanueva-Meyer, K. Boone, C.M. Mehringer, M. Lesser, et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology. 41: 1991; 1374–1382
- [147]C. Gregory, S. Lough, V. Stone, S. Erzinclioglu, L. Martin, S. Baron-Cohen, et al. Theory of mind in patients with frontal variant frontotemporal dementia and Alzheimer's disease: theoretical and practical implications. Brain. 125 (Pt 4): 2002; 752–764
- [148]C. Colosimo, A.J. Hughes, L. Kilford, A.J. Lees. Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry. 74: 2003; 852–856
- [149]M.D. Lezak, D.B. Howieson, D.W. Loring. Neuropsychological Assessment. 2004; Oxford University Press: New York
- [150]C.D. Morgan, L.E. Baade. Neuropsychological testing and assessment scales for dementia of the Alzheimer's type. Psychiatr Clin North Am. 20: 1997; 25–43
- [151]M. Sano. Neuropsychological testing in the diagnosis of dementia. J Geriatr Psychiatry Neurol. 19: 2006; 155–159
- [152]L.P. De Vreese, M. Neri, M. Fioravanti, L. Belloi, O. Zanetti. Memory rehabilitation in Alzheimer's disease: a review of progress. Int J Geriatr Psychiatry. 16: 2001; 794–809
- [153]H. Christensen, K. Griffiths, A. Mackinnon, P. Jacomb. A quantitative review of cognitive deficits in depression and Alzheimer-type dementia. J Int Neuropsychol Soc. 3: 1997; 631–651
- [154]M. Simard, R. Van Reekumm, T. Cohen. A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci. 12: 2000; 425–450
- [155]J.H. Kramer, J. Jurik, S.J. Sha, K.P. Rankin, H.J. Rosen, J.K. Johnson, et al. Distinctive neuropsychological patterns in frontotemporal dementia, semantic dementia, and Alzheimer disease. Cogn Behav Neurol. 16: 2003; 211–218
- [156]P.S. Mathuranath, P.J. Nestor, G.E. Berrios, W. Rakowicz, J.R. Hodges. A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology. 55: 2000; 1613–1620
- [157]M.L. Gorno-Tempini, N.F. Dronkers, K.P. Rankin, J.M. Ogar, L. Phengrasamy, H.J. Rosen, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 55: 2004; 335–346
- [158]J.R. Hodges, K. Patterson, R. Ward, P. Garrard, T. Bak, R. Perry, et al. The differentiation of semantic dementia and frontal lobe dementia (temporal and frontal variants of frontotemporal dementia) from early Alzheimer's disease: a comparative neuropsychological study. Neuropsychology. 13: 1999; 31–40
- [159]M. Sjogren, A. Wallin, A. Edman. Symptomatological characteristics distinguish between frontotemporal dementia and vascular dementia with a dominant frontal lobe syndrome. Int J Geriatr Psychiatry. 12: 1997; 656–661
- [160]N. Butters, J. Wolfe, M. Martone, E. Granholm, L.S. Cermak. Memory disorders associated with Huntington's disease: verbal recall, verbal recognition and procedural memory. Neuropsychologia. 23: 1985; 729–743